ELIXI International
Elixi International is a Swiss pharmaceutical wholesaler specializing in sourcing and delivering pharmaceutical products, medical devices, and drugs globally. They offer a comprehensive suite of services including wholesale trade, managed access programs, unlicensed medicines, clinical trial procurement, tenders for Ministries of Health, hospital supply, and Import/IOR for clinical trials. Elixi International differentiates itself with an AI-driven quality control system, 'Ambrogio,' developed in collaboration with SUPSI and approved by Swissmedic, which meticulously scans incoming products to minimize counterfeit risks. The company caters to a B2B market including hospitals, clinics, pharmaceutical and biotech companies, MOHs, CROs, and healthcare providers. Their business model is focused on wholesale and specialized distribution services.
ELIXI International
Elixi International is a Swiss pharmaceutical wholesaler specializing in sourcing and delivering pharmaceutical products, medical devices, and drugs globally. They offer a comprehensive suite of services including wholesale trade, managed access programs, unlicensed medicines, clinical trial procurement, tenders for Ministries of Health, hospital supply, and Import/IOR for clinical trials. Elixi International differentiates itself with an AI-driven quality control system, 'Ambrogio,' developed in collaboration with SUPSI and approved by Swissmedic, which meticulously scans incoming products to minimize counterfeit risks. The company caters to a B2B market including hospitals, clinics, pharmaceutical and biotech companies, MOHs, CROs, and healthcare providers. Their business model is focused on wholesale and specialized distribution services.